GE HealthCare Technologies Inc
GE HealthCare Technologies Inc/ US36266G1076 /
GEHC
29.07.2024 22:00:00
|
Diff.
+1.5500
|
Volumen |
Geld00:56:21 |
Brief00:56:21 |
Tageshoch |
Tagestief |
82.0500USD
|
+1.93%
|
2.79 Mio. Umsatz: 172.84 Mio. |
81.8000Geld Vol: 100 |
82.5000Brief Vol: 300 |
82.4590 |
80.5200 |
Unternehmensportrait
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients.
Vorstand & Aufsichtsrat
Vorstandsvorsitzender |
Peter J. Arduini |
Vorstand |
James (Jay) Saccaro, Betty Larson, Frank Jimenez, Jan Makela, Kevin O Neill, Thomas Westrick, Elie Chaillot, Catherine Estrampes, Rob Walton, Yihao Zhang, Ken Stacherski, Laila Gurney, Jahid Khandaker, Dr. Taha Kass-Hout, Brian Montgomery, Danielle Halstrom, Carolynne Borders, Abigail Epane-Osuala, Mike Donohoe, Roland Rott |
Aufsichtsrat |
Peter J. Arduini, H. Lawrence Culp, Jr., Dr. Rodney F. Hochman, Lloyd W. Howell, Jr., Dr. Risa Lavizzo-Mourey, Catherine Lesjak, Anne T. Madden, Dr. Tomislav Mihaljevic, William J. Stromberg, Phoebe L. Yang |
Unternehmensinformationen
Name: |
GE HealthCare Technologies Inc. |
Adresse: |
500 West Monroe Street,Chicago, IL 60661 |
Telefon: |
+1-617-443-3400 |
Fax: |
- |
E-Mail: |
-
|
Internet: |
www.gehealthcare.com |
Industrie: |
Gesundheitswesen |
Sektor: |
Medizintechnische Produkte |
Sub-Sektor: |
- |
Ende des Finanzjahres: |
31.12 |
Streubesitz: |
- |
IPO Datum: |
04.01.2023 |
Unternehmenskalender
KW 31 | 31.07.2024
Quartalszahlen 2. Quartal/Halbjahresbericht
|
KW 33 | 15.08.2024
Dividendenzahlung
|